News

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways IgA nephropathy is a progressive disease where immune proteins ...
Vor Bio partner RemeGen reports Phase 3 success for telitacicept in IgA nephropathy, showing a 55% drop in proteinuria and ...
Today, the American Kidney Fund (AKF) and the IgA Nephropathy Foundation, joined by more than 50 advocates living with rare kidney diseases, are convening on Capitol Hill to rally support for policy ...
IgA nephropathy, also known as Berger’s disease, is a progressive, autoimmune, chronic kidney disease that predominantly affects adults between the ages of 20 and 40. It is characterized by the ...
Integrating these practical measures into routine care allows for more nuanced assessment of treatment success and timely intervention when therapy adjustments are needed. Stay ahead of policy, cost, ...
May 11—(StatePoint) IgA nephropathy is a progressive, autoimmune, chronic disease that predominantly affects adults between the ages of 20 and 40, with an annual global incidence of 2.5 cases per ...
Early diagnosis and intervention create a return on investment model where up-front costs for screening, diagnosis, and early treatment yield substantial downstream cost savings while simultaneously ...
The event will highlight the Company’s CLYM116 program, a preclinical-stage monoclonal antibody targeting APRIL (A ...
Medically reviewed by David Hampton, MD Key Takeaways IgA nephropathy often has no symptoms for years, but when they appear, ...
IgA nephropathy can raise some big questions. Will your symptoms be so mild you hardly notice a change in daily life? Will you need dialysis one day? Should you prepare for a kidney transplant 10 or ...
IgA nephropathy is hard to predict. But there’s one thing experts know. People with strong emotional and social support systems tend do better in the long run. And it’s best to live your life to the ...
This transcript has been edited for clarity. Matthew A. Sparks, MD: Hi. I'm Dr Matthew Sparks. Welcome to Medscape's InDiscussion series on chronic kidney disease (CKD). Today, we'll be discussing ...